Literature DB >> 19022306

Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis.

Yue-Fa Cheng1, Guo-Qi Zhu, Mei Wang, Hui Cheng, An Zhou, Ning Wang, Nianbai Fang, Xun-Cui Wang, Xiao-Qiu Xiao, Zhi-Wu Chen, Qing-Lin Li.   

Abstract

It has been well documented that dysfunction of ubiquitin proteasome system (UPS) in the neuron exacerbated the Parkinson's disease (PD). However, whether or not UPS is involved in the protective effect of Puerarin on 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPP(+))-elicited cell death is yet to be elucidated. In this study, treatment of SH-SY5Y cells with 1mM MPP(+)-elicited a characteristic apoptotic cell death and pretreatment with Puerarin protected cells against MPP(+)-induced apoptosis as evidenced by promoting cell viability, improving morphological changes and reducing apoptotic rate. To further explore the potential protective mechanism of Puerarin in MPP(+)-induced SH-SY5Y cell death, UPS activity, mitochondria-dependent apoptosis and caspase-3 activity were measured. Puerarin pretreatment attenuated MPP(+)-induced dysfunction of protease activity, thereby reducing accumulation of ubiquitin-conjugated proteins. Meanwhile, caspase-3 activity was remarkably attenuated by Puerarin. In addition, the ratio of bcl-2/bax was increased by Puerarin in comparison with MPP(+)-treated group. Taken together, these results suggest that Puerarin could protect MPP(+)-induced SH-SY5Y cells from apoptosis by regulating the function of UPS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022306     DOI: 10.1016/j.neures.2008.10.009

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  21 in total

1.  Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons.

Authors:  Richard A Harbison; Kristen R Ryan; Heather M Wilkins; Emily K Schroeder; F Alexandra Loucks; Ron J Bouchard; Daniel A Linseman
Journal:  Neurotox Res       Date:  2010-03-24       Impact factor: 3.911

2.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

3.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

4.  DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.

Authors:  Xinglong Wang; Bo Su; Wanhong Liu; Xiaohua He; Yuan Gao; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Aging Cell       Date:  2011-06-14       Impact factor: 9.304

5.  Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade.

Authors:  Genling Jiang; Haiyun Wu; Yuqin Hu; Jun Li; Qinling Li
Journal:  Cell Mol Neurobiol       Date:  2014-03-12       Impact factor: 5.046

6.  GPR30 Activation Contributes to the Puerarin-Mediated Neuroprotection in MPP+-Induced SH-SY5Y Cell Death.

Authors:  Yue-Fa Cheng; Guoqi Zhu; Qing-Wen Wu; Yue-Sheng Xie; Yan Jiang; Lan Guo; Ya-Li Guan; Ying-Shuo Liu; Jun Zhang
Journal:  J Mol Neurosci       Date:  2016-10-30       Impact factor: 3.444

7.  Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy.

Authors:  Yukiko Sasazawa; Natsumi Sato; Kazuo Umezawa; Siro Simizu
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

8.  Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

Authors:  Diogo Martins Branco; Daniela M Arduino; A Raquel Esteves; Diana F F Silva; Sandra M Cardoso; Catarina Resende Oliveira
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

9.  hVMAT2: A Target of Individualized Medication for Parkinson's Disease.

Authors:  Nian Xiong; Nuomin Li; Eden Martin; Jinlong Yu; Jie Li; Jing Liu; David Yue-Wei Lee; Ole Isacson; Jeffery Vance; Hong Qing; Tao Wang; Zhicheng Lin
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

10.  SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Sookyoung Park; Mitsuyoshi Azuma; Jun Inoue; Naren L Banik
Journal:  J Neurochem       Date:  2013-12-16       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.